CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The goal of this study is to evaluate the safety and feasibility of defibrotide in COVID-19 pneumonia....
Phase 2
Boston, Massachusetts, United States
The proposed trial will obtain preliminary data on the feasibility of studying RTB101 as compared to placebo for COVID-19 post-expo...
Phase 2
Roslindale, Massachusetts, United States and 1 other location
The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...
Phase 3
Boston, Massachusetts, United States and 217 other locations
. There are no established monitoring nationwide protocols for COVID-19 prevention of infection. Due to the lack of such protocols,-...
Phase 1
Chelsea, Massachusetts, United States
States. The purpose of the study is to assess the safety and immunogenicity of recombinant influenza vaccine (RIV) + adjuvanted recombinant COVID...
Phase 1, Phase 2
Malden, Massachusetts, United States and 11 other locations
be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate CO-...
Phase 1
Boston, Massachusetts, United States and 32 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Boston, Massachusetts, United States and 66 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Worcester, Massachusetts, United States of America and 51 other locations
The purpose of this study is to evaluate the immunogenicity, reactogenicity, and safety, of mRNA-1083 multicomponent influenza and COVID-19...
Phase 2
Brookline, Massachusetts, United States and 16 other locations
study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...
Phase 2, Phase 3
Boston, Massachusetts, United States and 109 other locations
Clinical trials
Research sites
Resources
Legal